Literature DB >> 18762811

Epigenetic regulation of telomeres in human cancer.

E Vera1, A Canela, M F Fraga, M Esteller, M A Blasco.   

Abstract

Hypomethylation of repeated elements in the genome is a common feature of human cancer, however, the direct consequences of this epigenetic defect for cancer biology are still largely unknown. Telomeres are specialized chromatin structures at the ends of eukaryotic chromosomes formed by tandem repeats of G-rich sequences and associated proteins, which have an essential role in chromosome end protection and genomic stability. Telomeric DNA repeats cannot be methylated, however, the adjacent subtelomeric DNA is heavily methylated in humans. Here, we show that the methylation status of subtelomeric DNA repeats negatively correlates with telomere length and telomere recombination in a large panel of human cancer cell lines. These findings suggest that tumor telomere length and integrity can be influenced by epigenetic factors. Finally, we show that treatment of human cancer cell lines with demethylating drugs results in hypomethylation of subtelomeric repeats and increased telomere recombination, which in turn may facilitate telomere elongation. All together, these findings suggest that tumor telomere length and integrity can be influenced by the epigenetic status of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762811     DOI: 10.1038/onc.2008.289

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  50 in total

Review 1.  DNA methylation topology: potential of a chromatin landmark for epigenetic drug toxicology.

Authors:  Jian Tajbakhsh
Journal:  Epigenomics       Date:  2011-12       Impact factor: 4.778

2.  Analysis of DNA Methylation by Pyrosequencing.

Authors:  Colin Delaney; Sanjay K Garg; Raymond Yung
Journal:  Methods Mol Biol       Date:  2015

Review 3.  DNA hypomethylation in the origin and pathogenesis of human diseases.

Authors:  Igor P Pogribny; Frederick A Beland
Journal:  Cell Mol Life Sci       Date:  2009-03-27       Impact factor: 9.261

4.  Telomeric armor: the layers of end protection.

Authors:  Liana Oganesian; Jan Karlseder
Journal:  J Cell Sci       Date:  2009-11-15       Impact factor: 5.285

5.  CpG-island promoters drive transcription of human telomeres.

Authors:  Solomon G Nergadze; Benjamin O Farnung; Harry Wischnewski; Lela Khoriauli; Valerio Vitelli; Raghav Chawla; Elena Giulotto; Claus M Azzalin
Journal:  RNA       Date:  2009-10-22       Impact factor: 4.942

Review 6.  The tumorigenicity of human embryonic and induced pluripotent stem cells.

Authors:  Uri Ben-David; Nissim Benvenisty
Journal:  Nat Rev Cancer       Date:  2011-03-10       Impact factor: 60.716

7.  The relationship between DNA methylation and telomere length in dyskeratosis congenita.

Authors:  Shahinaz M Gadalla; Hormuzd A Katki; Fatma M Shebl; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Aging Cell       Date:  2011-11-15       Impact factor: 9.304

8.  Individual telomere lengths in chronic myeloid leukemia.

Authors:  Oumar Samassekou; Aimé Ntwari; Josée Hébert; Ju Yan
Journal:  Neoplasia       Date:  2009-11       Impact factor: 5.715

9.  Telomerase activity is associated with an increase in DNA methylation at the proximal subtelomere and a reduction in telomeric transcription.

Authors:  Laura J Ng; Jennifer E Cropley; Hilda A Pickett; Roger R Reddel; Catherine M Suter
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

Review 10.  A 'higher order' of telomere regulation: telomere heterochromatin and telomeric RNAs.

Authors:  Stefan Schoeftner; Maria A Blasco
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.